![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 39/09 | (2006.01) |
A61K 39/385 | (2013.01) | ||
A61K 39/385 | (2006.01) | ||
A61K2039/55544 | (2013.01) | ||
A61K 39/00 | (2006.01) | ||
A61K2039/58 | (2013.01) | ||
A61K2039/70 | (2013.01) | ||
A61K 39/092 | (2013.01) | ||
A61P 11/00 | (2018.01) | ||
A61P 31/04 | (2018.01) | ||
A61P 37/04 | (2018.01) |
(11) | Patento numeris | 3244917 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 16702585.7 |
Europos patento paraiškos padavimo data | 2016-01-05 | |
(97) | Europos patento paraiškos paskelbimo data | 2017-11-22 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2023-04-19 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/IB2016/050036 |
Data | 2016-01-05 |
(87) | Numeris | WO 2016/113644 |
Data | 2016-07-21 |
(30) | Numeris | Data | Šalis |
201562103630 P | 2015-01-15 | US |
(72) |
COOPER, David , US
JANSEN, Kathrin Ute , US
PRIDE, Michael William , US
|
(73) |
Pfizer Inc. ,
66 Hudson Boulevard East, New York, NY 10001-2192,
US
|
(54) | IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES |
IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES |